Re: nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT. Article uri icon

Overview

publication date

  • September 1, 2015

Research

keywords

  • Androgen Antagonists
  • Prostatic Neoplasms, Castration-Resistant
  • Testosterone

Identity

Scopus Document Identifier

  • 84940532747

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2015.05.027

PubMed ID

  • 26282354

Additional Document Info

volume

  • 68

issue

  • 3